Top 3 Legislative Priorities for Pharmacists

The National Community Pharmacists Association (NCPA) recently asked its independent pharmacy members to rank the most significant legislative and regulatory priorities for 2017, according to a press release.
"NCPA's annual survey of independent community pharmacies helps focus our advocacy efforts, which take on more urgency with a new Congress and president taking office,” NCPA CEO B. Douglas Hoey, RPh, MBA, said in a statement.
According to the survey, the top 3 concerns for pharmacists in 2018 were:
1. Ending Direct and Indirect Remuneration (DIR) fees
Many pharmacists have expressed concern over DIR fees and how this system jeopardizes pharmacies and the patients they treat.
Read more of our DIR fee coverage here.
“This year's top priorities are tied to the questionable business practices of lightly-regulated PBM corporations,” Hoey said. “Complaints about DIR fees have skyrocketed, so it is not surprising that reining in PBM clawbacks would top the list.”
2. Increasing Generic Drug Reimbursement Transparency
In addition to the adverse effects of DIR fees, pharmacies also indicated that reimbursement rates continue to threaten businesses.
“The second and third highest ranked priorities are long-standing, PBM-generated challenges—the lack of transparency with generic prescription drug reimbursements,” Hoey said in the statement.
3. Including the Any Willing Pharmacy Provision to Part D Plans
Respondents indicated that the preferred pharmacy designation may prohibit independent pharmacies from providing care to patients and may reduce overall business.
“Medicare Part D's ‘preferred pharmacy' plans that prevent independent community pharmacy patients from having access to discounted co-pays,” Hoey said.
NCPA said that it plans to work with Congress and the Trump administration to introduce legislation that will remedy these concerns.
"While not part of the survey questioning, NCPA also is equally focused on the changed political landscape and potentially dramatic changes in health care,” Hoey concluded. “As a result, we will make sure the voice of independent community pharmacies is heard. Our main objective is always to maintain patient access to prescription drug services at community pharmacies and continue pushing for pharmacists to be fully utilized as clinically-trained medication experts who improve health outcomes while reducing costs."

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Most Popular

Related Articles

A data-centric approach is vital for patients with complex conditions, particularly in determining what has worked well and anticipating what medical or pharmacy care is required for effective outcomes in the future.
The shift from fee-based, volume-driven care to value-based, patient-centered care and the growth of specialty pharmaceuticals are propelling us all into uncharted territory, no matter what role you play in health care.
The value of big data in health care is realized when raw data are transformed into insights that drive practice change and decision making.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.